Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients

被引：0
|
作者：
Rollison, Dana E. [1 ]
Shain, Kenneth H. [1 ]
Lee, Ji-Hyun [2 ]
Hampras, Shalaka S. [1 ]
Fulp, William [1 ]
Fisher, Kate [1 ]
Al Ali, Najla H. [1 ]
Padron, Eric [3 ]
Lancet, Jeffrey [1 ]
Xu, Qiang [4 ]
Knight, Robert D. [4 ]
List, Alan F. [1 ]
Dalton, William [1 ]
Komrokji, Rami [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA
[3] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[4] Celgene Corp, Summit, NJ USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A Phase I/II Study of the Combination of Oral Rigosertib and Azacitidine in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
    Navada, Shyamala C.
    Garcia-Manero, Guillermo
    Wilhelm, Francois
    Hearn, Katherine
    Odchimar-Reissig, Rosalie
    Demakos, Erin P.
    Alvarado, Yesid
    Daver, Naval
    DiNardo, Courtney D.
    Konopleva, Marina
    Borthakur, Gautam
    Azarnia, Nozar
    Silverman, Lewis R.
    [J]. BLOOD, 2014, 124 (21)
  • [42] MIDOSTAURIN (MIDO) DEMONSTRATES A FAVORABLE SAFETY PROFILE IN OLDER PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYNDROME (MDS)
    Fischer, T.
    Kantarjian, H.
    Feldman, E.
    Ehninger, G.
    Larson, P.
    Khan, M.
    Virkus, J.
    Stone, R.
    [J]. HAEMATOLOGICA, 2013, 98 : 30 - 30
  • [43] Predictors Of Response To Rigosertib In Patients With a Myelodysplastic Syndrome (MDS) Or Acute Myeloid Leukemia (AML) Relapsing After Or Refractory To Hypomethylating Agents
    Navada, Shyamala C.
    Odchimar-Reissig, Rosalie
    Reddy, E. Premkumar
    Demakos, Erin P.
    Holland, James F.
    Wilhelm, Francois
    Silverman, Lewis R.
    [J]. BLOOD, 2013, 122 (21)
  • [44] Dose reduced conditioning and allogeneic stem cell transplantation in 34 patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Bornhauser, M
    Kroschinsky, F
    Ulrike, S
    Markus, S
    Eberhard, S
    Ralph, N
    Thiede, C
    Ulrich, S
    Gerhard, E
    [J]. BLOOD, 2000, 96 (11) : 780A - 780A
  • [45] ECONOMIC IMPACT OF TRANSFORMATION TO ACUTE MYELOID LEUKEMIA (AML) AMONG PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HIGHER-RISK MDS) IN THE UNITED STATES: RETROSPECTIVE MATCHED COHORT STUDY
    Kota, V.
    Ogbonnaya, A.
    Farrelly, E.
    Schroader, B. Kanz
    Kristo, F.
    Raju, A.
    Dalal, M.
    [J]. LEUKEMIA RESEARCH, 2021, 108 : S26 - S27
  • [46] End of Life (EOL) Metrics in Older Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)
    LoCastro, M.
    Baran, A. M.
    Liesveld, J.
    Becker, M. W.
    O'Dwyer, K. M.
    Husehon, E.
    Aljitawi, O. S.
    Baumgart, M.
    Snyder, E.
    Kluger, B.
    Mendler, J. H.
    Loh, K.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S285 - S285
  • [47] Molecular and Cytogenetic Characteristics of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) in Patients Exposed to Chemotherapy (CT) and/or Radiation (XRT)
    Desai, Pinkal
    Abaza, Yasmin
    Carraway, Hetty E.
    Chua, Jason
    Samuel, Michael
    Crispino, Cynthia
    Foley, Bridget
    Veeraballi, Sindhusha
    Doukas, Peter
    Odetola, Oluwatobi
    Kaner, Justin D.
    Bar-Natan, Michal
    Ritchie, Ellen K.
    Roboz, Gail J.
    [J]. BLOOD, 2023, 142
  • [48] Dose reduced conditioning and allogeneic stem cell transplantation in 36 patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
    Bornhäuser, M
    Schaich, M
    Schaekel, U
    Mahlberg, R
    Clemens, M
    Ehninger, G
    [J]. BONE MARROW TRANSPLANTATION, 2001, 27 : S85 - S85
  • [49] Comprehensive Analysis of Safety: Rigosertib in 557 Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
    Garcia-Manero, Guillermo
    Fenaux, Pierre
    Al-Kali, Aref
    Navada, Shyamala C.
    Baer, Maria R.
    Raza, Azra
    Greenberg, Peter
    Kreuzer, Karl-Anton
    Hiwase, Devendra K.
    Roboz, Gail J.
    Santini, Valeria
    Platzbecker, Uwe
    Petrone, Michael E.
    Brownstein, Bernard
    Zbyszewski, Patrick Simon
    Maniar, Manoj
    Silverman, Lewis R.
    [J]. BLOOD, 2016, 128 (22)
  • [50] WHO classification af acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)
    Haferlach, T
    Schoch, C
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (09) : 447 - 450
12345